Regeneron and Sanofi cut Praluent list price
FDA promises speedy review of Keytruda in head and neck cancer
Verily builds US drug rehab campus
Shockwave Medical plans IPO
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*